Style | Citing Format |
---|---|
MLA | Moghimipour E, Abedini M, Handali S. "Targeted Solid Lipid Nanoparticles Formulation for Colon Cancer Treatment and Cytotoxicity Assessment Using Ht29 Cell Line." Jundishapur Journal of Natural Pharmaceutical Products, vol. 18, no. 2, 2023, pp. -. |
APA | Moghimipour E, Abedini M, Handali S (2023). Targeted Solid Lipid Nanoparticles Formulation for Colon Cancer Treatment and Cytotoxicity Assessment Using Ht29 Cell Line. Jundishapur Journal of Natural Pharmaceutical Products, 18(2), -. |
Chicago | Moghimipour E, Abedini M, Handali S. "Targeted Solid Lipid Nanoparticles Formulation for Colon Cancer Treatment and Cytotoxicity Assessment Using Ht29 Cell Line." Jundishapur Journal of Natural Pharmaceutical Products 18, no. 2 (2023): -. |
Harvard | Moghimipour E, Abedini M, Handali S (2023) 'Targeted Solid Lipid Nanoparticles Formulation for Colon Cancer Treatment and Cytotoxicity Assessment Using Ht29 Cell Line', Jundishapur Journal of Natural Pharmaceutical Products, 18(2), pp. -. |
Vancouver | Moghimipour E, Abedini M, Handali S. Targeted Solid Lipid Nanoparticles Formulation for Colon Cancer Treatment and Cytotoxicity Assessment Using Ht29 Cell Line. Jundishapur Journal of Natural Pharmaceutical Products. 2023;18(2):-. |
BibTex | @article{ author = {Moghimipour E and Abedini M and Handali S}, title = {Targeted Solid Lipid Nanoparticles Formulation for Colon Cancer Treatment and Cytotoxicity Assessment Using Ht29 Cell Line}, journal = {Jundishapur Journal of Natural Pharmaceutical Products}, volume = {18}, number = {2}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Moghimipour E AU - Abedini M AU - Handali S TI - Targeted Solid Lipid Nanoparticles Formulation for Colon Cancer Treatment and Cytotoxicity Assessment Using Ht29 Cell Line JO - Jundishapur Journal of Natural Pharmaceutical Products VL - 18 IS - 2 SP - EP - PY - 2023 ER - |